AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atanasova, B. D
Right arrow Articles by Simpson, R. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atanasova, B. D
Right arrow Articles by Simpson, R. J
Agricola
Right arrow Articles by Atanasova, B. D
Right arrow Articles by Simpson, R. J
American Journal of Clinical Nutrition, Vol. 81, No. 1, 130-133, January 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Duodenal ascorbate and ferric reductase in human iron deficiency1,2,3

Bisera D Atanasova, Andy CY Li, Ingvar Bjarnason, Kamen N Tzatchev and Robert J Simpson

1 From the Department of Clinical Laboratory and Clinical Immunology, Medical University, Sofia, Bulgaria; the Division of Life Sciences, King's College London, London; the Gastrointestinal Laboratory, The Rayne Institute, St Thomas' Hospital, London; and the Department of Medicine, GKT School of Medicine, King's College, London

Background: The first step in iron absorption requires the reduction of ferric iron to ferrous iron, a change that is catalyzed by duodenal ferric reductase. Iron deficiency is associated with high iron absorption, high ferric reductase activity, and high duodenal ascorbate concentrations in experimental animals, but it is not known whether a relation between reductase and ascorbate is evident in humans.

Objective: The objective of the study was to assess the relation between ferric reductase activity in human duodenal biopsy specimens and ascorbate concentrations in iron-replete and iron-deficient subjects.

Design: Patients and control subjects were overnight-fasted adults presenting sequentially for upper gastrointestinal endoscopic investigation. Ferric reductase activity in duodenal biopsy specimens was assayed by using nitroblue tetrazolium. Ascorbate was assayed in duodenal biopsy specimens and plasma.

Results: Iron-deficient patients had significantly higher reductase activity (n = 6–9; P < 0.05) and duodenal (n = 20; P < 0.001) and plasma (n = 6; P < 0.001) ascorbate concentrations than did control subjects. Incubation of biopsy specimens with dehydroascorbate (to boost cellular ascorbate) increased reductase activity in the tissues that initially had normal activity (n = 9; P < 0.01) but inhibited reductase activity in the tissues that already had high reductase activity (n = 13; P < 0.001).

Conclusions: Iron deficiency in humans is associated with increased duodenal ascorbate concentrations. This finding suggests that increased reductase activity is partly due to an increase in this substrate for duodenal cytochrome b reductase 1.

Key Words: Iron absorption • iron nutrition • vitamin C




This article has been cited by other articles:


Home page
J. Nutr.Home page
G. O. Latunde-Dada, R. J. Simpson, and A. T. McKie
Duodenal Cytochrome B Expression Stimulates Iron Uptake by Human Intestinal Epithelial Cells
J. Nutr., June 1, 2008; 138(6): 991 - 995.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition